Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

11. Juni 2014 08:00 ET | Quelle: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Appoints Melissa Bradford Klug as Senior Vice President of Business Development and Strategy

WALTHAM, Mass., June 11, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced the appointment of Melissa Bradford Klug as senior vice president of business development and...
06. Juni 2014 08:00 ET | Quelle: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Announces Patent Term Extension for Ferumoxytol in the U.S.

WALTHAM, Mass., June 6, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that the United States Patent and Trademark Office (USPTO) has issued a U.S. patent term...
13. Mai 2014 08:00 ET | Quelle: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. to Present at the UBS Global Healthcare Conference

WALTHAM, Mass., May 13, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that William Heiden, AMAG's chief executive officer, will present at the UBS Global Healthcare...
28. April 2014 08:00 ET | Quelle: AMAG Pharmaceuticals, Inc.

Study Showing Effectiveness of MuGard(R) for Management of Oral Mucositis Featured in the Journal Cancer

WALTHAM, Mass., April 28, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that the publication of data from a multi-institutional trial of MuGard has been featured in...
24. April 2014 07:00 ET | Quelle: AMAG Pharmaceuticals, Inc.

AMAG Announces First Quarter 2014 Financial Results

17% Total Revenue Growth, Driven by Strong Feraheme Performance Favorable Terms Achieved in Recent $200 Million Convertible Debt Offering Ending Cash Balance of $385 Million Provides Capital for...
22. April 2014 08:00 ET | Quelle: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. to Host Conference Call on April 24, 2014 at 8:00 a.m. ET to Discuss Financial Results for the Quarter Ended March 31, 2014

WALTHAM, Mass., April 22, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced it will report unaudited consolidated financial results for the quarter ended March 31, 2014...
16. April 2014 17:00 ET | Quelle: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Announces Appointment of Jim Sulat to Its Board of Directors and the Transition of Chairman Role to Gino Santini

WALTHAM, Mass., April 16, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced new appointments to its board of directors. Current board member, Gino Santini, has been...
01. April 2014 17:00 ET | Quelle: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. to Present at the Needham Healthcare Conference

WALTHAM, Mass., April 1, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that William Heiden, AMAG's chief executive officer, will present at the 13th Annual Needham...
27. Februar 2014 08:00 ET | Quelle: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. to Participate in the Cowen and Company 34th Annual Healthcare Conference

WALTHAM, Mass., Feb. 27, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that William Heiden, AMAG's chief executive officer, will present at the Cowen and Company...
25. Februar 2014 08:00 ET | Quelle: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Appoints Edward Jordan as Senior Vice President of Sales and Marketing

WALTHAM, Mass., Feb. 25, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced the appointment of Edward Jordan as senior vice president of sales and marketing. Mr. Jordan...

Vorherige Seite